Xinkai Kujiang Treatment improves gastrointestinal microbiota and inhibits the IL-17 signaling pathway to ameliorate spasmolytic polypeptide expressing metaplasia in mice (PRJCA037361)
To explore the therapeutic effect and potential regulatory mechanism of Xinkai Kujiang Treatment on spasmolytic polypeptide expressing metaplasia ( SPEM ) in gastric mucosa of mice.